PLoS ONE · 2016 · 14 citations · 34 references
Life SciencesBiochemistryNeuroscienceMolecular NeurobiologyMolecular NeuroscienceNeurodegenerationAlzheimer DiseaseAmyloid FormationNeurodegenerative DiseasesPhage DisplayProtein AggregationProtein OligomerizationAmyloid Beta AggregationAmyloid Beta PeptidesAmyloid Oligomer FormationNeuroprotective MechanismsNeuroprotective PeptidesOligomer ToxicityPeptide AggregationPeptide Display Technologies
Alzheimer´s disease is the most prominent type of dementia and currently no causative treatment is available. According to recent studies, oligomeric species of the amyloid beta (Aβ) peptide appear to be the most toxic Aβ assemblies. Aβ monomers, however, may be not toxic per se and may even have a neuroprotective role. Here we describe a competitive mirror image phage display procedure that allowed us to identify preferentially Aβ1-42 monomer binding and thereby stabilizing peptides, which destabilize and thereby eliminate toxic oligomer species. One of the peptides, called Mosd1 (monomer specific d-peptide 1), was characterized in more detail. Mosd1 abolished oligomers from a mixture of Aβ1-42 species, reduced Aβ1-42 toxicity in cell culture, and restored the physiological phenotype in neuronal cells stably transfected with the gene coding for human amyloid precursor protein.
34
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Jie Kang, Hans-Georg Lemaire, Axel Unterbeck et al. · Nature · 1987 · 4.6K citations
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Dietmar Rudolf Thal, Udo Rüb, M Orantes et al. · Neurology · 2002 · 3.5K citations
Dementia: a public health priority
Daisy Acosta, Ennapadam S. Krishnamoorthy, Marc Wortmann et al. · 2012 · 2K citations